WE
PMD

Wealth Effects’s Psychemedics Corporation PMD Stock Holding History

Wealth Effects’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-40,701
Closed -$162K – 240
2023
Q3 		$162K Sell
40,701
-800
-2% -$3.57K 0.08% 171
2023
Q2 		$189K Sell
41,501
-3,000
-7% -$15.2K 0.08% 178
2023
Q1 		$234K Hold
44,501
– – 0.12% 162
2022
Q4 		$218K Hold
44,501
– – 0.12% 162
2022
Q3 		$287K Sell
44,501
-800
-2% -$5.14K 0.18% 122
2022
Q2 		$287K Buy
45,301
+5,300
+13% +$34K 0.17% 127
2022
Q1 		$276K Sell
40,001
-1,457
-4% -$10.3K 0.13% 148
2021
Q4 		$291K Buy
+41,458
New +$332K 0.12% 153

Other funds holding PMD

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIC
Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return

Wealth Effects's PMD Position: Q4 2023 in Review

Wealth Effects sold out of Psychemedics Corporation (PMD) in Q4 2023, closing a stake of 40,701 shares — an estimated $162K sold.

Wealth Effects first reported a position in PMD in Q4 2021 and held it in 8 quarters. The position peaked at $291K in Q4 2021. 23 funds tracked by Wall St. Rank hold PMD as of Q4 2023.

  • Wealth Effects reported no remaining Psychemedics Corporation position as of Q4 2023 after selling out during the quarter.
  • Wealth Effects sold 40,701 Psychemedics Corporation shares in Q4 2023, an estimated $162K.
  • Wealth Effects first reported a position in Psychemedics Corporation in Q4 2021 and held it in 8 quarters.
  • Wealth Effects's Psychemedics Corporation position peaked at $291K in Q4 2021.
  • 23 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q4 2023.

Based on Wealth Effects's 13F filing for Q4 2023, filed 29 Jan 2024.